A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

A pizza shop with 30 delivery people ought to be able to deliver a lot of pizzas - if their cars don't break down on the way. Likewise, genes that produce a lot of messenger RNA (mRNA) molecules can ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

Moderna’s new Laval-based facility supports onshore vaccine production, bolsters health and economic resilience, and ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...